ScholarIQanswers from OpenAlex

Effect of mepolizumab in airway remodeling in patients with late-onset severe asthma with an eosinophilic phenotype

PaperCitations, authors & open-access status

Effect of mepolizumab in airway remodeling in patients with late-onset severe asthma with an eosinophilic phenotype is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Effect of mepolizumab in airway remodeling in patients with late-onset severe asthma with an eosinophilic phenotype have?

ScholarIQcitation count

Effect of mepolizumab in airway remodeling in patients with late-onset severe asthma with an eosinophilic phenotype has 53 citations in the OpenAlex counts ScholarIQ stores.

When was Effect of mepolizumab in airway remodeling in patients with late-onset severe asthma with an eosinophilic phenotype published?

ScholarIQyear

Effect of mepolizumab in airway remodeling in patients with late-onset severe asthma with an eosinophilic phenotype has 2024 year in the ScholarIQ index.

What is the open-access status of Effect of mepolizumab in airway remodeling in patients with late-onset severe asthma with an eosinophilic phenotype?

ScholarIQoa status

Effect of mepolizumab in airway remodeling in patients with late-onset severe asthma with an eosinophilic phenotype has hybrid oa status in the ScholarIQ index.

What is the DOI of Effect of mepolizumab in airway remodeling in patients with late-onset severe asthma with an eosinophilic phenotype?

ScholarIQdoi

The DOI for Effect of mepolizumab in airway remodeling in patients with late-onset severe asthma with an eosinophilic phenotype is on the source record.

What is the PMID of Effect of mepolizumab in airway remodeling in patients with late-onset severe asthma with an eosinophilic phenotype?

ScholarIQpmid

The PMID for Effect of mepolizumab in airway remodeling in patients with late-onset severe asthma with an eosinophilic phenotype is on the source record.

What is the OpenAlex record for Effect of mepolizumab in airway remodeling in patients with late-onset severe asthma with an eosinophilic phenotype?

ScholarIQopenalex

The OpenAlex for Effect of mepolizumab in airway remodeling in patients with late-onset severe asthma with an eosinophilic phenotype is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial